(+)-CC-1065 produces bending of DNA that appears to resemble adenine/thymine tracts.
(+)-CC-1065 produces bending of DNA that appears to resemble adenine/thymine tracts.
复制标题
( )-CC-1065 产生类似于腺嘌呤/胸腺嘧啶束的 DNA 弯曲。
DOI:
10.1021/tx00019a003
复制
发表时间:
1991
影响因子:
4.1
通讯作者:
Hurley,LH
中科院分区:
文献类型:
--
作者:
Lin,CH;Sun,DY;Hurley,LH
Facilitated by the extensive array of analogues synthesized byUpjohn scientists (12), structure-activity re-lationships have been sharply defined (Figure 1). Of particular significance is our observation that the A subunit of (+)-CC-1065 has sufficient structural information to elicit the sequence specificity of the entire drug molecule, although the nature of B and C subunits can modulate or fine tune this specificity (Figure 1)(6b). In previous publications (6b, c, 10b) we have argued that the primary basis for the sequence selectivity of (+)-CC-1065 is a se-quence-dependent catalytic activation and/or a se-quence-dependent conformational flexibility. In contrast to this result, we have recently demonstrated that the sequence selectivity of (-)-CC-1065, the synthetic enan-tiomer, is largely determined by noncovalent binding interactions. Adenine/thymine tracts (A-tracts) in DNA have been demonstrated by gel electrophoresis (13), elec-tron microscopy (14), X-ray diffraction (15), and hydroxyl-radical footprinting (16) to produce bends in DNA. The precise structural basis for the A-tract-associatedbend in DNA is still controversial (17), but the junction bend model (13) seems to be the most probable. Both high-field XH NMR (19) and hydroxyl-radical footprinting (20) results are consistent with narrowing of the minor groove due to a high propeller twist angle in an AT base pair at the junction site as a structural basis for thiseffect. In this communication we demonstrate, using hydroxyl-radical footprinting and high-field proton NMR, that the bend in DNA, which is entrapped or induced by (+)-CC-1065, appears to resemble in overall respects a naturally oc-curring A-tract bend. The possible relationship of this bend to sequence selectivity and biological consequences of such a feature associated with a potent DNA-reactive drug are discussed.